Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxi-Rio doxycycline post-exposure prophylaxis pilot study
RBR-7jkmhf5Not yet recruiting
- Sponsor
- Evandro Chagas National Institute of Infectology
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of doxycycline in bacterial sexually transmitted diseases, syphilis, Chlamydia trachomatis infection and 1 more (2 arms), sponsored by Evandro Chagas National Institute of Infectology. Primary endpoint: Incidence of bacterial sexually transmitted infections. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
doxycycline
03
Conditions
bacterial sexually transmitted diseasessyphilisChlamydia trachomatis infectiongonorrhea
Beyond the preview
Go deeper on RBR-7jkmhf5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-7jkmhf5.